Table 1.
Compound | Correlation | Target |
---|---|---|
Apicidin | −0.260 | HDAC1, HDAC2, HDAC3, HDAC6, HDAC8 |
SAHA | −0.201 | HDAC1, HDAC2, HDAC3, HDAC6, HDAC8 |
Belinostat | −0.447 | HDAC1, HDAC2, HDAC3, HDAC6, HDAC8 |
Panobinostat | −0.258 | HDAC1, HDAC2, HDAC3, HDAC6, HDAC8 |
Entinostat | −0.133 | HDAC1, HDAC2, HDAC3, HDAC6, HDAC8 |
ISOX | −0.0554 | HDAC6 |
Tubastatin A | −0.221 | HDAC6 |
BRD-A94377914 | −0.171 | HDAC1, HDAC2, HDAC3, HDAC6, HDAC8 |
Merck 60 | −0.187 | HDAC1, HDAC2 |
BRD-K80183349 | −0.195 | HDAC1, HDAC2, |
BRD-K24690302 | −0.158 | HDAC1 |
* Pearson correlation coefficients between HDAC inhibitors sensitivity data, expressed as areas under concentration-response curves (AUCs), with DHRS2-expression measurements, expressed as log2 robust-multi-array-average values.